The cholinergic anti-inflammatory pathway in chronic kidney disease-review and vagus nerve stimulation clinical pilot study
Hilderman M, Bruchfeld A
Nephrology Dialysis Transplantation · 2020
Key finding
Controlling inflammation by neuroimmune modulation may lead to new therapeutic modalities for improved treatment, outcome, prognosis and quality of life for patients with CKD.
- Condition
- Inflammation
- Stimulation
- iVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Hilderman, M., & Bruchfeld, A. (2020). The cholinergic anti-inflammatory pathway in chronic kidney disease-review and vagus nerve stimulation clinical pilot study. Nephrology Dialysis Transplantation, 35(11), 1840-1852. https://doi.org/10.1093/ndt/gfaa200
Related studies in Inflammation
Vagus nerve stimulation in autoimmune conditions: a systematic review
Lombo et al. · ACR Open Rheumatology · 2025 · Systematic Review / Meta-Analysis
No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: a systematic review and meta-analysis
Schiweck et al. · Brain, Behavior, and Immunity · 2024 · Systematic Review / Meta-Analysis
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes
Okdahl et al. · Scientific Reports · 2024 · Randomised Controlled Trial
Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
Stavrakis et al. · JACC. Clinical electrophysiology · 2024 · Randomised Controlled Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.